Capital Investment Counsel Inc Sells 536 Shares of The Clorox Company (NYSE:CLX)

Capital Investment Counsel Inc decreased its position in shares of The Clorox Company (NYSE:CLX) by 18.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,400 shares of the company’s stock after selling 536 shares during the quarter. Capital Investment Counsel Inc’s holdings in Clorox were worth $390,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in CLX. State Street Corp grew its position in shares of Clorox by 3.1% during the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after buying an additional 245,525 shares during the period. Mizuho Securities USA LLC grew its position in shares of Clorox by 46,877.8% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after buying an additional 4,490,421 shares during the period. Geode Capital Management LLC grew its position in shares of Clorox by 1.1% during the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after buying an additional 33,970 shares during the period. Stifel Financial Corp grew its position in shares of Clorox by 1.7% during the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock worth $380,370,000 after buying an additional 37,967 shares during the period. Finally, Van ECK Associates Corp grew its position in shares of Clorox by 2.2% during the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after buying an additional 31,510 shares during the period. Institutional investors own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

CLX has been the subject of several recent analyst reports. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. DA Davidson reduced their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and lifted their price target for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Finally, Evercore ISI lifted their price target on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Four research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $158.21.

Clorox Price Performance

Shares of NYSE:CLX opened at $152.93 on Friday. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The stock’s fifty day simple moving average is $158.11 and its two-hundred day simple moving average is $159.68. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The stock has a market cap of $18.84 billion, a PE ratio of 41.78, a price-to-earnings-growth ratio of 2.54 and a beta of 0.42.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the firm posted $2.16 EPS. As a group, analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.